Results 251 to 260 of about 140,562 (355)
Pulmonary hypertension caused by fibrosing mediastinitis has a five‐year survival rate of just 56%. Current diagnostic approaches are complex for patients with mobility limitations and can lead to misdiagnoses due to their nonspecific clinical features.
Yating Zhao+17 more
wiley +1 more source
Technical Report of Radiofrequency Ablation of AVNRT with Persistent Left Superior Vena Cava: Success Relies on Basics. [PDF]
Elhadad MA+9 more
europepmc +1 more source
Superior vena cava syndrome after heart transplantation: percutaneous treatment of a complication of bicaval anastomoses [PDF]
Daniel Y. Sze+4 more
openalex +1 more source
ABSTRACT A simple and selective high‐performance liquid chromatography bioanalytical method was developed and validated to determine the pharmacokinetic parameters of 5‐[1‐(4‐fluorophenyl)‐1H‐pyrazol‐4‐yl]‐2H‐tetrazole (LQFM020) with promising vasorelaxant, anti‐inflammatory, and antinociceptive properties while verifying its potential hepatic enzyme ...
Lanussy Porfiro de Oliveira+10 more
wiley +1 more source
Iatrogenic Superior Vena Cava Syndrome With Extensive Thromboembolism Associated With Chronic Indwelling Catheterization. [PDF]
Song X, Whittles J, Ding X.
europepmc +1 more source
Surgery of the thoracic aorta with hypothermic circulatory arrest: experience with retrograde perfusion via the superior vena cava and demonstration of cerebral perfusion [PDF]
Duilio Pagano+3 more
openalex +1 more source
ABSTRACT Immunochemotherapy has demonstrated high cure rates in primary mediastinal large B‐cell lymphoma (PMBCL). Recent findings from the IELSG 37 study show that certain specific dose‐dense treatment regimens are more likely to eliminate the need for consolidative radiation therapy, thereby reducing long‐term toxicity. Here, we report our experience
Robin Noel+16 more
wiley +1 more source
A Case of Cavernous Sinus Dural Arteriovenous Fistula with Persistent Left Superior Vena Cava. [PDF]
Nakamura H+4 more
europepmc +1 more source